Severe steroid-induced glaucoma following intravitreal injection of triamcinolone acetonide.
OBJECTIVE
To report a case of severe corticosteroid-induced glaucoma after intravitreal injection of triamcinolone acetate in a 34-year-old man without a history of glaucoma.


METHODS
Observational case report.


METHODS
Retrospective review of a clinical case.


RESULTS
A 34-year-old man acquired visual field defects and severe vision loss in both eyes after intravitreal injection of triamcinolone for diabetic macular edema.


CONCLUSIONS
Intravitreal injection of triamcinolone is a commonly performed treatment for many retinal conditions. This treatment has the potential to cause severe vision loss as a result of intractable corticosteroid-induced glaucoma.
Jules Stein Eye Institute, David Geffen/UCLA School of Medicine, 100 Stein Plaza, Los Angeles, CA 90095, USA. pollyquiram@yahoo.com
Polly A
PA
Quiram
Christine R
CR
Gonzales
Steven D
SD
Schwartz
D000328:Adult; D000959:Antihypertensive Agents / Q000627:therapeutic use; D003930:Diabetic Retinopathy / Q000188:drug therapy; D005451:Fluorescein Angiography; D005901:Glaucoma / Q000139:chemically induced* / Q000188:drug therapy; D005938:Glucocorticoids / Q000009:adverse effects*; D006801:Humans; D007267:Injections; D007429:Intraocular Pressure; D008269:Macular Edema / Q000188:drug therapy; D008297:Male; D012189:Retrospective Studies; D014222:Triamcinolone Acetonide / Q000009:adverse effects*; D014786:Vision Disorders / Q000139:chemically induced; D014794:Visual Fields / Q000187:drug effects; D014822:Vitreous Body
D000959:Antihypertensive Agents; D005938:Glucocorticoids; D014222:Triamcinolone Acetonide